Related references
Note: Only part of the references are listed.Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients
George Cholankeril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Attitudes of Liver Transplant Candidates Toward Organs From Increased-Risk Donors
Sapna S. Humar et al.
LIVER TRANSPLANTATION (2019)
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma
Nicole E. Rich et al.
Clinical Gastroenterology and Hepatology (2019)
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
Stacey B. Prenner et al.
JOURNAL OF HEPATOLOGY (2017)
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns et al.
LANCET INFECTIOUS DISEASES (2016)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Share Paper
